Some motorists could be at risk of fines of up to £1,000 if they don't get in contact with the DVLA as soon as possible. A ...

There are a wide range of health conditions that could potentially affect your driving, and as a result you must tell the ...

Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access information on a device and to provide personalised ads and content, ad and ...

The Diabetes Prevention Program is entering its second series of Lifestyle Change Program classes to help people with ...

The University of Oulu is at the forefront of developing cutting-edge biosensor technology that could revolutionize the early diagnosis and treatment of diseases.

A small study found that drinking ketones improved heart efficiency in type 2 diabetes patients, supporting the hypothesis ...

Glucotrack has successfully completed its first in-human clinical study for the first real-time, continuous blood glucose monitor (CBGM) placed in the subclavian vein.

Gonzaga University and the UW School of Medicine hosted Irl Hirsch to lecture about the future of glucose monitoring.

Eversense 365 is the world’s first and only one year CGM, which was approved by the United States (US) Food and Drug Administration in September of 2024 and launched across the country in October of ...

Fourteen-day continuous glucose monitoring (CGM) traces added to Diabetes Control and Complications Trial (DCCT) data can predict microvascular diabetes complications similarly to glycated hemoglobin.

Shanghai's Ruijin Hospital announced today that researchers have developed a groundbreaking non-invasive blood glucose ...

The US Food and Drug Administration (FDA) is cautioning patients and caregivers about the potential for not receiving blood ...